Medical News

RSS

It's never too late to take control of diabetes

"You could live a normal life." Those were the words that 15-year-old Steve Edelman kept hearing from the nurses when he was hospitalized following his type 1 diabetes diagnosis in 1970. He wondered why they kept repeating this to him.

2 May 2012

Online assessment tool for stroke

Nearly 800,000 Americans will suffer a stroke this year, yet most people in the U.S. cannot identify stroke warning signs or risk factors. HealthONE Stroke Care hopes to change that during May's National Stroke Awareness Month with the introduction of its new Stroke Risk Profiler, an online assessment tool for adults of all ages

2 May 2012

Grape-derived compound may prevent neurodegenerative disorders involving tau neuropathology

Researchers at Mount Sinai School of Medicine have gained insight into the mechanism by which a pathological brain protein called tau contributes to the progression of Alzheimer's disease (AD) and other neurodegenerative disorders. This finding, published in the most recent issue of the Journal of Biological Chemistry, may provide the basis for future investigations on how to prevent tau from damaging brain circuits involved in cognitive function.

2 May 2012

Biosynthetic polyphenol may improve cognitive function in Alzheimer's disease patients

Mount Sinai School of Medicine researchers have succeeded in developing a biosynthetic polyphenol that improves cognitive function in mice with Alzheimer's disease (AD). The findings, published in a recent issue of the Journal of Neuroscience, provide insight in determining the feasibility of biosynthetic polyphenols as a possible therapy for AD in humans, a progressive neurodegenerative disease for which there is currently no cure.

2 May 2012

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active, a patented cranberry-based oral capsule clinically shown to support urinary tract health.

2 May 2012

ImmuVen awarded $1.68M NIH Phase II SBIR grant to develop IMV0123

ImmuVen was awarded a Phase II Small Business Innovation Research (SBIR) grant totaling $1.68 million from the National Institute for Allergy and Infectious Disease (NIH) for continuing development of its therapeutic pipeline (IMV0123) against superantigens produced by methicillin-sensitive and methicillin-resistant Staphylococcal aureus.

2 May 2012

Older Americans experience significant and troubling gaps in primary care

Large majorities of older Americans experience significant and troubling gaps in their primary care, according to a new national survey, "How Does It Feel? The Older Adult Health Care Experience," released today by the John A. Hartford Foundation, a champion for improved geriatric care and longtime partner of the Hartford Institute for Geriatric Nursing at New York University's College of Nursing.

2 May 2012

Expression of tyrosine kinases may limit effectiveness of agents against sarcomas

To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.

2 May 2012

Nanocomposite dental cavity-filling kills harmful bacteria

Scientists using nanotechology at the University of Maryland School of Dentistry have created the first cavity-filling composite that kills harmful bacteria and regenerates tooth structure lost to bacterial decay.

2 May 2012

Lobbyists drive up taxpayer costs by obstructing state efforts to reform Medicaid drug programs

By obstructing state efforts to reform Medicaid drug programs, lobbyists drive up taxpayer costs, according to a new study by the National Center for Policy Analysis (NCPA).

2 May 2012

Acute need for more effective treatments for pediatric obesity

With nearly one-third of American children being overweight or obese, doctors agree that there is an acute need for more effective treatments. In many weight management programs, the dropout rate can be as high as 73 percent, and even in successful programs, the benefits are usually short term.

2 May 2012

Solta Medical first quarter revenue increases 23% to $32.5 million

Solta Medical, Inc., a global leader in the medical aesthetics market, today announced results for the first quarter ended March 31, 2012. Revenue for the first quarter was $32.5 million, an increase of $6.0 million, or 23%, as compared to the first quarter of 2011.

2 May 2012

Blood services workers on strike in Michigan, Ohio

The American Red Cross is viciously attacking its workforce in the Midwest. More than 300 qualified, hardworking unionized blood services workers remain on strike over plans by Red Cross that would destabilize blood supply safety and strip workers of their collective bargaining rights.

2 May 2012

FDA permits Percutaneous Surgical Set for minimally invasive laparoscopic abdominal surgery

On April 30, the U.S. Food and Drug Administration today allowed marketing of the first surgical instrument set that can be assembled and disassembled inside the body during surgery.

2 May 2012

Viora offers Reaction Rent-to-Own program to medical aesthetic practitioners in Canada

Viora is excited to announce that its popular "Rent-to-Own" program for Reaction™ will now be offered in Canada to medical aesthetic practitioners. Now Canadian physicians will have the ability to introduce the leading medical aesthetic device for body contouring and skin tightening into their practice at minimal risk - with no capital investment, no financing, and no long term commitment.

2 May 2012

Rigel first quarter net loss increases to $23.2 million

Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2012.

2 May 2012

Different genes involved in autism tend to be involved in specific processes in the brain

Autism has a strong genetic basis, but so far efforts to identify the responsible genes have had mixed results. The reason for this is that autism is influenced by many different genes, and different genes are involved in different individuals, making it hard to find the common genetic ground between patients.

2 May 2012

Lower rate of reintubation observed in infants receiving SURFAXIN

Discovery Laboratories, Inc. today announced the presentation of a new pharmacoeconomic analysis demonstrating that the lower rate of reintubation previously reported in infants treated with SURFAXIN, when compared with infants treated with Curosurf® and Survanta®, the current global market leading surfactants, also resulted in a potential hospital cost savings of $160,000 to $252,000 per 100 infants.

2 May 2012

Novo Nordisk granted exclusive rights to Caisson's heparosan-based drug delivery technology

Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, announced today that it has entered into a Development and License Agreement with Novo Nordisk A/S, a global healthcare company and leader in diabetes care.

From Novo Nordisk 2 May 2012

Dixie announces new hemp-based Cannabidiol products without THC

Dixie Elixirs and Edibles, Colorado's premier Tetrahydrocannabinol or THC-infused products company, today announced a new line of products which will break entirely new ground for the company in the category of non-THC-infused product development.

2 May 2012

Medical News

It's never too late to take control of diabetes

Online assessment tool for stroke

Grape-derived compound may prevent neurodegenerative disorders involving tau neuropathology

Biosynthetic polyphenol may improve cognitive function in Alzheimer's disease patients

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

ImmuVen awarded $1.68M NIH Phase II SBIR grant to develop IMV0123

Older Americans experience significant and troubling gaps in primary care

Expression of tyrosine kinases may limit effectiveness of agents against sarcomas

Nanocomposite dental cavity-filling kills harmful bacteria

Lobbyists drive up taxpayer costs by obstructing state efforts to reform Medicaid drug programs

Acute need for more effective treatments for pediatric obesity

Solta Medical first quarter revenue increases 23% to $32.5 million

Blood services workers on strike in Michigan, Ohio

FDA permits Percutaneous Surgical Set for minimally invasive laparoscopic abdominal surgery

Viora offers Reaction Rent-to-Own program to medical aesthetic practitioners in Canada

Rigel first quarter net loss increases to $23.2 million

Different genes involved in autism tend to be involved in specific processes in the brain

Lower rate of reintubation observed in infants receiving SURFAXIN

Novo Nordisk granted exclusive rights to Caisson's heparosan-based drug delivery technology

Dixie announces new hemp-based Cannabidiol products without THC

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News